![Dan A. Giampuzzi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Mr. Giampuzzi most recently served as President and CEO of Gemin X Biotechnologies Inc., a Montreal/Philadelphia-based private biotechnology company that specializes in the discovery and development of novel small molecule cancer therapeutics based on the regulation of apoptosis, the body's natural ability to destroy injured or damaged cells.
During his nine years at Gemin X, he successfully raised over $100 million in private venture capital financing from international firms and assembled a highly capable team that has put over 12 cancer drugs into the clinic and six onto the market today.
Previous to Gemin X he worked in senior management roles for such organizations as MDS Capital Corp., Searle Canada Inc. and Merrell Dow Pharmaceuticals.
Mr. Giampuzzi earned a Bachelor of Science and an MBA from the University of Toronto.
Anciens postes connus de Dan A. Giampuzzi
| Sociétés | Poste | Fin |
|---|---|---|
Ventures West Management, Inc.
 Ventures West Management, Inc. Investment ManagersFinance Ventures West Management invests in early-stage technology companies across Canada. They focus on investments in biotechnology, clean technology and communications. Ventures West Management is an active value-added venture capital partner. The firm contributes resources to ensure that portfolio companies build value. Ventures West often has representation on the board of directors of their portfolio companies. The firm looks for companies with experienced management teams, competitive advantages and attractive markets. They target early-stage companies that are seeking seed or Series A funding. The firm also looks for companies with the potential for a profitable exit within 4 to 6 years | Private Equity Investor | 01/12/2008 |
Gemin X Pharmaceuticals US, Inc.
 Gemin X Pharmaceuticals US, Inc. BiotechnologyHealth Technology Develops cancer therapeutic products | President | 31/07/2007 |
Formation de Dan A. Giampuzzi
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
17
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Ventures West Management, Inc.
Ventures West Management, Inc. Investment ManagersFinance Ventures West Management invests in early-stage technology companies across Canada. They focus on investments in biotechnology, clean technology and communications. Ventures West Management is an active value-added venture capital partner. The firm contributes resources to ensure that portfolio companies build value. Ventures West often has representation on the board of directors of their portfolio companies. The firm looks for companies with experienced management teams, competitive advantages and attractive markets. They target early-stage companies that are seeking seed or Series A funding. The firm also looks for companies with the potential for a profitable exit within 4 to 6 years | Finance |
University of Toronto
 University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gemin X Pharmaceuticals US, Inc.
Gemin X Pharmaceuticals US, Inc. BiotechnologyHealth Technology Develops cancer therapeutic products | Health Technology |
Choisissez Zonebourse 
